Page 46 - GPD-1-2
P. 46

Gene & Protein in Disease                                            RUNX1 gene in female-related cancers



               identification of novel prognostic and predictive signatures.      https://doi.org/10.1002/ijc.29210
               PLoS One, 6: e28403.
                                                               125. Jemal  A, Bray  F, Center MM,  et al., 2011,  Global  cancer
               https://doi.org/10.1371/journal.pone.0028403       statistics. CA Cancer J Clin. 61(2): 69–90.
            115. Hnisz D, Abraham BJ, Lee TI, et al., 2013, Super‐enhancers      https://doi.org/10.3322/caac.20107
               in the control of cell identity and disease. Cell, 155: 934–947.
                                                               126. WCRF International. 2021, Ovarian Cancer Statistics. World
               https://doi.org/10.1016/j.cell.2013.09.053         Cancer Research Fund International. Available from: https://
                                                                  www.wcrf.org/dietandcancer/ovarian-cancer-statistics [Last
            116. Browne G, Taipaleenmaki H, Bishop NM, et al., 2015, RUNX1
               is associated with breast cancer progression in MMTV‐  accessed on 2021 Oct 25].
               PyMT transgenic mice and its depletion in vitro inhibits   127. Mills K, Fuh K, 2017, Recent advances in understanding,
               migration and invasion. J Cell Physiol, 230: 2522–2532.   diagnosing, and treating ovarian cancer. F1000Research, 6: 84.
               https://doi.org/10.1002/jcp.24989                  https://doi.org/10.12688/f1000research.9977.1
            117. Kadota M, Yang HH, Gomez B,  et al., 2010, Delineating   128. Vogelstein B, Papadopoulos N, Velculescu VE, et al., 2013,
               genetic alterations for tumor progression in the MCF10A   Cancer genome landscapes. Science, 339(6127): 1546–1558.
               series of breast cancer cell lines. PLoS One, 5: e9201.
                                                                  https://doi.org/10.1126/science.1235122
               https://doi.org/10.1371/journal.pone.0009201
                                                               129. Yu H, Pardoll D, Jove R,  et al., 2009, STATs in cancer
            118. Bokhman JV, 1983, Two pathogenetic types of endometrial   inflammation and immunity: A leading role for STAT3. Nat
               carcinoma. Gynecol Oncol, 15: 10–17.               Rev Cancer, 9(11): 798–809.
               https://doi.org/10.1016/0090-8258(83)90111-7       https://doi.org/10.1038/nrc2734
            119. Planaguma J, Abal M, Gil‐Moreno A,  et al., 2005, Up‐  130. Monge M, Colas E, Doll A,  et al., 2007, ERM/ETV5
               regulation of ERM/ETV5 correlates with the degree of   up-regulation plays a role during myometrial infiltration
               myometrial infiltration in endometrioid endometrial   through  matrix  metalloproteinase-2  activation  in
               carcinoma. J Pathol, 207: 422–429.                 endometrial cancer. Cancer Res, 67(14): 6753–6759.
               https://doi.org/10.1002/path.1853.                 https://doi.org/10.1158/0008-5472.CAN-06-4487
            120. Planaguma J, Liljestrom M, Alameda F, et al., 2011, Matrix   131. Aylward J, 2021, Global Burden of Cervical Cancer-together
               metalloproteinase‐2 and matrix metalloproteinase‐9   for Health TogetHER for Health. Available from: https://
               codistribute with transcription factors RUNX1/AML1 and   togetherforhealth.org/global-burden-cervical-cancer  [Last
               ETV5/ERM at the invasive front of endometrial and ovarian   accesed on 2021 Oct 25].
               carcinoma. Hum Pathol, 42: 57–67.
                                                               132. SEER, 2022, Cancer of the Cervix Uteri Cancer Stat Facts.
               https://doi.org/10.1016/j.humpath.2010.01.025      Available  from:  https://seer.cancer.gov/statfacts/html/
                                                                  cervix.html [Last accessed on 2022 Sep 22].
            121. Atienza JM, Roth RB, Rosette C, et al., 2005, Suppression of
               RAD21 gene expression decreases cell growth and enhances   133. Laronda MM, Unno K, Ishi K, et al., 2013, Diethylstilbestrol
               cytotoxicity of etoposide and bleomycin in human breast   induces  vaginal  adenosis  by  disrupting  SMAD/RUNX1-
               cancer cells. Mol Cancer Ther 4: 361–368.          mediated cell fate decision in the Müllerian duct epithelium.
                                                                  Dev Biol, 381: 5–16.
               https://doi.org/10.1158/1535-7163.MCT-04-0241
                                                                  https://doi.org/10.1016/j.ydbio.2013.06.024
            122. Rhodes DR, Yu J, Shanker K, et al., 2004, Large‐scale meta‐
               analysis of cancer microarray data identifies common   134. Terakawa J, Rocchi A, Serna VA, et al., 2016, FGFR2IIIb-
               transcriptional profiles of neoplastic transformation and   MAPK activity is required for epithelial cell fate decision in
               progression. Proc Natl Acad Sci U S A 101: 9309–9314.   the lower Müllerian duct. Mol Endocrinol, 30: 783–795.
               https://doi.org/10.1073/pnas.0401994101            https://doi.org/10.1210/me.2016-1027
            123. Alonso‐Alconada L, Muinelo‐Romay L, Madissoo K, et al.,   135. Robboy SJ, Young RH, Welch WR,  et al., 1984, Atypical
               2014, Molecular profiling of circulating tumor cells links   vaginal adenosis and cervical ectropion. Association with
               plasticity to the metastatic process in endometrial cancer.   clear cell adenocarcinoma in diethylstilbestrol-exposed
               Mol Cancer, 13: 223.                               offspring. Cancer, 54: 869–875.
               https://doi.org/10.1186/1476-4598-13-223           https://doi.org/10.1002/1097-0142(19840901)54:5<869:aid-
                                                                  cncr2820540519>3.0.co;2-i
            124. Ferlay J, Soerjomataram I, Dikshit R, et al., 2015, Cancer
               incidence and mortality worldwide: Sources, methods and   136. Cerami E, Gao J, Dogrusoz U,  et al., 2012, The cBio
               major patterns in GLOBOCAN 2012. Int J Cancer, 136(5):   cancer genomics  portal: An open platform for exploring
               E359–E386.                                         multidimensional  cancer  genomics  data.  Cancer Discov,


            Volume 1 Issue 2 (2022)                         17                     https://doi.org/10.36922/gpd.v1i2.147
   41   42   43   44   45   46   47   48   49   50   51